These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36786105)

  • 1. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
    Kuwana M; Bando M; Kawahito Y; Sato S; Suda T; Kondoh Y;
    Expert Rev Respir Med; 2023 Jan; 17(1):71-80. PubMed ID: 36786105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and management of interstitial lung disease associated with systemic sclerosis (SSc-ILD), rheumatoid arthritis (RA-ILD), and polymyositis/dermatomyositis (PM/DM-ILD): development of expert consensus-based clinical algorithms.
    Kondoh Y; Bando M; Kawahito Y; Sato S; Suda T; Kuwana M
    Expert Rev Respir Med; 2024 Jun; 18(6):447-456. PubMed ID: 38943279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
    Khanna D; Mittoo S; Aggarwal R; Proudman SM; Dalbeth N; Matteson EL; Brown K; Flaherty K; Wells AU; Seibold JR; Strand V
    J Rheumatol; 2015 Nov; 42(11):2168-71. PubMed ID: 25729034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.
    Saketkoo LA; Mittoo S; Huscher D; Khanna D; Dellaripa PF; Distler O; Flaherty KR; Frankel S; Oddis CV; Denton CP; Fischer A; Kowal-Bielecka OM; LeSage D; Merkel PA; Phillips K; Pittrow D; Swigris J; Antoniou K; Baughman RP; Castelino FV; Christmann RB; Christopher-Stine L; Collard HR; Cottin V; Danoff S; Highland KB; Hummers L; Shah AA; Kim DS; Lynch DA; Miller FW; Proudman SM; Richeldi L; Ryu JH; Sandorfi N; Sarver C; Wells AU; Strand V; Matteson EL; Brown KK; Seibold JR;
    Thorax; 2014 May; 69(5):428-36. PubMed ID: 24368713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases.
    Lv C; Zhang Q; Tang P; Guo L; Ding Q
    Adv Rheumatol; 2022 Oct; 62(1):37. PubMed ID: 36303230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
    Kondoh Y; Makino S; Ogura T; Suda T; Tomioka H; Amano H; Anraku M; Enomoto N; Fujii T; Fujisawa T; Gono T; Harigai M; Ichiyasu H; Inoue Y; Johkoh T; Kameda H; Kataoka K; Katsumata Y; Kawaguchi Y; Kawakami A; Kitamura H; Kitamura N; Koga T; Kurasawa K; Nakamura Y; Nakashima R; Nishioka Y; Nishiyama O; Okamoto M; Sakai F; Sakamoto S; Sato S; Shimizu T; Takayanagi N; Takei R; Takemura T; Takeuchi T; Toyoda Y; Yamada H; Yamakawa H; Yamano Y; Yamasaki Y; Kuwana M;
    Respir Investig; 2021 Nov; 59(6):709-740. PubMed ID: 34602377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
    Saketkoo LA; Mittoo S; Frankel S; LeSage D; Sarver C; Phillips K; Strand V; Matteson EL; ;
    J Rheumatol; 2014 Apr; 41(4):792-8. PubMed ID: 24488412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of interstitial lung disease associated with connective tissue disease.
    Mathai SC; Danoff SK
    BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
    Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
    BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining respiratory impairment in connective tissue disease-associated interstitial lung disease.
    Assayag D; Ryerson CJ
    Rheum Dis Clin North Am; 2015 May; 41(2):213-23. PubMed ID: 25836638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.
    Hoffmann-Vold AM; Maher TM; Philpot EE; Ashrafzadeh A; Barake R; Barsotti S; Bruni C; Carducci P; Carreira PE; Castellví I; Del Galdo F; Distler JHW; Foeldvari I; Fraticelli P; George PM; Griffiths B; Guillén-Del-Castillo A; Hamid AM; Horváth R; Hughes M; Kreuter M; Moazedi-Fuerst F; Olas J; Paul S; Rotondo C; Rubio-Rivas M; Seferian A; Tomčík M; Uzunhan Y; Walker UA; Więsik-Szewczyk E; Distler O
    Lancet Rheumatol; 2020 Feb; 2(2):e71-e83. PubMed ID: 38263663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
    Pugashetti JV; Khanna D; Kazerooni EA; Oldham J
    Immunol Allergy Clin North Am; 2023 May; 43(2):411-433. PubMed ID: 37055096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease.
    Pugashetti JV; Khanna D; Kazerooni EA; Oldham J
    Rheum Dis Clin North Am; 2024 Aug; 50(3):439-461. PubMed ID: 38942579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
    Wallace B; Vummidi D; Khanna D
    Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease in China].
    Zou QH; Lu YW; Zhou JG; Liu XX; Li MT; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1217-1223. PubMed ID: 36323562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
    Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
    BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment and management of connective tissue disease-associated interstitial lung disease.
    Fischer A; Chartrand S
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):2-21. PubMed ID: 26237351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.